Merck Serono, a division of German's Merck KGaA, has announced a new five-year clinical development agreement with Quintiles. This strategic collaboration is the first-of-its-kind between a ...

Diatech Pharmacogenetics Expands Collaboration with Merck to Enhance Patient Access to Personalized Medicine in the Middle East and AfricaBusiness Wire via ITWeb,JESI, Italy, 29 Jan 2025Diatech ...

with the German firm’s Merck Serono division licensing various technologies used to engineer T-cells to target cancers, including its RheoSwitch platform for controlling gene expression and ...

In Europe and Canada, where the drug is marketed by Geneva-based Merck Serono and Serono of Mississauga, Ontario, respectively, regulators have taken Raptiva off the market, stating that the ...